Announced Tue, 21 Jul · 12:02 IST
Analyst/investor meet scheduled for 3rd August 2026
Board & Shareholder Meetings View source PDF
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.2%1-day move
₹2499.00
prior close
₹2473.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0—+0.1+0.1+2.2+0.2+0.8+2.2——————
Up moveDown movePending
AI summary
GlaxoSmithKline Pharma has informed the stock exchanges that a group analyst and institutional investor meeting is scheduled for 3rd August 2026 in digital mode. This is filed under SEBI Listing Regulations. The company noted only publicly available information will be shared, and the date may change due to scheduling issues.
Likely market impact
Routine disclosure with no new material info; unlikely to move the stock price meaningfully.